Patent number 3,174,137, which is titled Gut Microbiota Bioactivated PDE4 Inhibitor Precursors, encompasses the composition ...

The patient has a rash on her cheeks and nose with sparing of the nasolabial folds, in addition to involvement of the dorsal ...

PALI-2108 is the first and only PDE4 inhibitor designed to target terminal ileum and colon for fibrostenotic Crohn’s disease (FSCD) and ulcerative colitis (UC) to address significant unmet medical ...

Tiny gold particles that act as carriers for lithium can be delivered directly to the brain in the form of a nasal spray.

This is the result of work carried out by researchers at the Università Cattolica del Sacro Cuore/Fondazione Policlinico Universitario A. Gemelli IRCCS at Rome in collaboration with the University of ...

Researchers at the First Affiliated Hospital of the University of Science and Technology of China claim that an in vivo CD8 T ...

Researchers from the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), have developed a novel ...

Patients with interstitial lung disease in systemic sclerosis demonstrate distinct intestinal microbiota that may help identify pathogenesis and targeted treatments, according to data published in ...

When: The CMMC final rule went into effect in December 2024 and will start appearing in contracts at the end of 2025. Why it matters: The Defense Department is on the cusp of implementing the ...

Neoadjuvant CTLA-4/PD-(L)1 Blockade Versus Surgery +/− Chemotherapy in Deficient Mismatch Repair/Microsatellite Instability–High Resectable Gastroesophageal Adenocarcinoma: Individual Patient Data ...

The covert surveillance of journalists and lawyers by police in Northern Ireland was not "widespread or systemic", an independent review has found. However, the McCullough Review has identified more ...